A JAK2/IDH1-mutant MPN clone unmasked by ivosidenib in an AML patient without antecedent MPN

BLOOD ADVANCES

AMER SOC HEMATOLOGY

1. Conquer Cancer Foundation
2. Leukemia & Lymphoma Society
3. Truth 365
4. Mark Foundation for Cancer Research
5. ASH Scholar Award
6. Cancer Center Support grant from the National Institutes of Health National Cancer Institute [P30 CA008748]